Another September and another IIR MDRP conference has passed. Attendance was respectable in Chicago year, although the subject matter was perhaps a little more sedate than last year with HCR now 18 months old.
Howard Dean was the keynote speaker (reflecting the usual D to R to D pattern here for political keynotes), who used his medical training to good stead in his speech while...
The US Government is once again going through the process of redefining how it prices drugs that are purchased for the Medicaid program. The last time this occurred was as a direct result of the Deficit Reduction Act and cascaded into 2 years of turmoil as an interim rule was created that was later succeeded by a final rule which changed much of what was in the interim rule.
Late last...